Pfizer Inc. (BMV:PFE)

Market Cap	2.61T
Revenue (ttm)	1.20T
Net Income (ttm)	202.66B
Shares Out	n/a
EPS (ttm)	35.70
PE Ratio	12.89
Forward PE	8.96
Dividend	33.53 (7.23%)
Ex-Dividend Date	Jul 25, 2025

Volume	2,699
Average Volume	44,760
Open	468.81
Previous Close	470.32
Day's Range	463.93 - 468.93
52-Week Range	427.00 - 593.09
Beta	0.47
RSI	47.46
Earnings Date	Nov 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD